276 related articles for article (PubMed ID: 17185919)
1. [Neck dissection for stage N0 oral cavity carcinoma].
Jegoux F; Cazé A; Mohr E; Godey B; Le Clech G
Ann Otolaryngol Chir Cervicofac; 2006 Nov; 123(5):221-6. PubMed ID: 17185919
[TBL] [Abstract][Full Text] [Related]
2. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
[TBL] [Abstract][Full Text] [Related]
3. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
4. Selective neck dissection is effective in N1/N2 nodal stage oral cavity squamous cell carcinoma.
Battoo AJ; Hedne N; Ahmad SZ; Thankappan K; Iyer S; Kuriakose MA
J Oral Maxillofac Surg; 2013 Mar; 71(3):636-43. PubMed ID: 22884115
[TBL] [Abstract][Full Text] [Related]
5. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
Koo BS; Lim YC; Lee JS; Choi EC
Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
[TBL] [Abstract][Full Text] [Related]
6. Oral maxillary squamous carcinoma: an indication for neck dissection in the clinically negative neck.
Montes DM; Carlson ER; Fernandes R; Ghali GE; Lubek J; Ord R; Bell B; Dierks E; Schmidt BL
Head Neck; 2011 Nov; 33(11):1581-5. PubMed ID: 21990223
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of selective lymph node dissection in clinically negative neck.
Mira E; Benazzo M; Rossi V; Zanoletti E
Otolaryngol Head Neck Surg; 2002 Oct; 127(4):279-83. PubMed ID: 12402005
[TBL] [Abstract][Full Text] [Related]
8. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
[TBL] [Abstract][Full Text] [Related]
9. Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.
Schmitz S; Machiels JP; Weynand B; Gregoire V; Hamoir M
Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):437-43. PubMed ID: 18648835
[TBL] [Abstract][Full Text] [Related]
10. Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.
Bajwa MS; McMillan R; Khattak O; Thomas M; Krishnan OP; Webster K
Head Neck; 2011 Mar; 33(3):403-6. PubMed ID: 20629073
[TBL] [Abstract][Full Text] [Related]
11. Results of a randomized controlled trial of level IIb preserving neck dissection in clinically node-negative squamous carcinoma of the oral cavity.
Pandey M; Karthikeyan S; Joshi D; Kumar M; Shukla M
World J Surg Oncol; 2018 Nov; 16(1):219. PubMed ID: 30409212
[TBL] [Abstract][Full Text] [Related]
12. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
13. Outcome of observing the N0 neck using ultrasonographic-guided cytology for follow-up.
van den Brekel MW; Castelijns JA; Reitsma LC; Leemans CR; van der Waal I; Snow GB
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):153-6. PubMed ID: 10037281
[TBL] [Abstract][Full Text] [Related]
14. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer.
Ross G; Shoaib T; Soutar DS; Camilleri IG; Gray HW; Bessent RG; Robertson AG; MacDonald DG
Arch Otolaryngol Head Neck Surg; 2002 Nov; 128(11):1287-91. PubMed ID: 12431172
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in lieu of neck dissection for staging oral cancer.
Rigual N; Loree T; Frustino J; Jayaprakash V; Cohan D; Sullivan M; Kuriakose MA
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):779-82. PubMed ID: 23868306
[TBL] [Abstract][Full Text] [Related]
16. Elective neck dissection in oral carcinoma: a critical review of the evidence.
Kowalski LP; Sanabria A
Acta Otorhinolaryngol Ital; 2007 Jun; 27(3):113-7. PubMed ID: 17883186
[TBL] [Abstract][Full Text] [Related]
17. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
18. Supraomohyoid neck dissection in the management of oral squamous cell carcinoma: special consideration for skip metastases at level IV or V.
Feng Z; Li JN; Niu LX; Guo CB
J Oral Maxillofac Surg; 2014 Jun; 72(6):1203-11. PubMed ID: 24480771
[TBL] [Abstract][Full Text] [Related]
19. Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks.
Zbären P; Nuyens M; Caversaccio M; Stauffer E
Am J Surg; 2006 Jun; 191(6):756-60. PubMed ID: 16720144
[TBL] [Abstract][Full Text] [Related]
20. Management of contralateral N0 neck in pyriform sinus carcinoma.
Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]